Drug profile · INN
raloxifene
EVISTA
raloxifene (EVISTA) is a estrogen receptor beta modulator. Associated with Lacuna Pharma Pty Ltd.
EMA: approved TGA: approved Genito-urinary system and sex hormones (G03) G03XC01
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — raloxifene
- Class
- Genito-urinary system and sex hormones (G03)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
raloxifene (EVISTA) is a estrogen receptor beta modulator. Associated with Lacuna Pharma Pty Ltd.
Key facts
INN raloxifene
Brand EVISTA
Mechanism Estrogen receptor beta modulator
Target Estrogen receptor
Therapeutic class Genito-urinary system and sex hormones (G03)
ATC code G03XC01
Originator Lacuna Pharma Pty Ltd
Mechanism of action
Estrogen receptor beta modulator
Primary target: Estrogen receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is raloxifene?
raloxifene (EVISTA) is a estrogen receptor beta modulator. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for raloxifene?
EVISTA is a marketed brand name for raloxifene. Check FDA Drugs@FDA for the current US label holder and prescribing information.